Dermato-pulmonary syndrome associated with MDA-5 antibodies

Yurdagül Uzunhan (Bobigny, France), Yurdagül Uzunhan, Hilario Nunes, Gaelle Leroux, Makoto Miyara, Olivier Benveniste, Yves Allenbach

Source: International Congress 2016 – Dealing with the complexity of critically-ill patients
Session: Dealing with the complexity of critically-ill patients
Session type: Thematic Poster
Number: 2138
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Yurdagül Uzunhan (Bobigny, France), Yurdagül Uzunhan, Hilario Nunes, Gaelle Leroux, Makoto Miyara, Olivier Benveniste, Yves Allenbach. Dermato-pulmonary syndrome associated with MDA-5 antibodies. Eur Respir J 2016; 48: Suppl. 60, 2138

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Antisynthetase syndrome (AS) in patients with diffuse interstitial lung disease (ILD)
Source: International Congress 2015 – Connective tissue disorders
Year: 2015

Idiopathic non-specific interstitial pneumonia (iNSIP): do the patients develop connective tissue disease (CTD) during follow-up?
Source: International Congress 2016 – Connective tissue disorders
Year: 2016

Dermato-pulmonary syndrome associated with MDA-5 antibodies: Report of the first French series
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013

The role of detection of myositis specific and associated antibodies in Japanese patient with interstitial lung disease
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014


Clinical characteristics of 30 patients with interstitial pneumonia associated with anti-aminoacyl-tRNA-synthetase antibodies
Source: International Congress 2016 – Connective tissue disorders
Year: 2016


Study of factors affecting mortality in ILD cases over 2 years
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016


OSA with intertitial lung diseases
Source: International Congress 2016 – Effect of sleep apnoea on life-span and comorbidities
Year: 2016

Rituximab in severe, progressive interstitial lung disease
Source: International Congress 2016 – Connective tissue disorders
Year: 2016

Addition of respiratory hospitalizations 24weeks prior to the ILD-GAP model to predict mortality in chronic interstitial lung disease
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016


Detection of anti DFS70 antibodies in patients with interstitial lung disease (ILD) with and without connective tissue disease (CTD)
Source: International Congress 2016 – Connective tissue disorders
Year: 2016

Clinical analysis of lung manifestation in Sjögren's syndrome
Source: Annual Congress 2013 –Diffuse parenchymal lung disease II
Year: 2013

Usefulness of a myositis antibody immunoblot in diagnosis of connective tissue disease (CTD) related interstitial lung disease (ILD)
Source: International Congress 2014 – ILDs 4
Year: 2014


ILD-India registry: Idiopathic pulmonary fibrosis (IPF) and connective tissue disease (CTD) associated interstitial lung disease (CTD-ILD)
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016


A multicentre evaluation of inter-multidisciplinary team agreement for diagnosis in diffuse lung disease
Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases
Year: 2016

A multicentre evaluation of inter-multidisciplinary team agreement for predicted disease behaviour and management strategy in diffuse lung disease
Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases
Year: 2016

Are there any clinical differences between SSc-ILD and UCTD suspected of SSc -ILD?
Source: International Congress 2015 – Connective tissue disorders
Year: 2015


Rituximab in severe, treatment-refractory interstitial lung disease
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013

Pattern and impact of rheumatology referral in patients with ILD and autoimmune features
Source: International Congress 2016 – Connective tissue disorders
Year: 2016


Prognostic factors of interstitial lung disease associated with primary Sjögren's syndrome
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013


Co-morbidities and cause of death in patients with rheumatoid arthritis associated interstitial lung disease
Source: International Congress 2015 – Connective tissue disorders
Year: 2015